Microarray-based analysis of gene expression profiles in peripheral blood of patients with acute primary angle closure

References

• Congdon N, Wang F, Tielsch JM. Issues in the epidemiology and population-based screening of primary angle-closure glaucoma. Surv Ophthalmol 1992;36:411–423.
   PubMed Web of Science ®Google Scholar
• Foster PJ, Johnson GJ. Glaucoma in China: how big is the problem? Br J Ophthalmol 2001;85:1277–1282.
   PubMed Web of Science ®Google Scholar
• Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. Jama 2014;311:1901–1911.
   PubMed Web of Science ®Google Scholar
• He M, Foster PJ, Johnson GJ, et al. Angle-closure glaucoma in East Asian and European people different diseases? Eye 2006;20:3–12.
   PubMed Web of Science ®Google Scholar
• Takai Y, Tanito M, Ohira A. Multiplex cytokine analysis of aqueous humor in eyes with primary open-angle glaucoma, exfoliation glaucoma, and cataract. Invest Ophthalmol Vis Sci 2012;53:241–247.
   PubMed Web of Science ®Google Scholar
• Chua J, Vania M, Cheung CM, et al. Expression profile of inflammatory cytokines in aqueous from glaucomatous eyes. Mol Vis 2012;18:431–438.
   PubMed Web of Science ®Google Scholar
• Huang W, Chen S, Gao X, et al. Inflammation-related cytokines of aqueous humor in acute primary angle-closure eyes. Invest Ophthalmol Vis Sci 2014;55:1088–1094.
   PubMed Web of Science ®Google Scholar
• Du S, Huang W, Zhang X, et al. Multiplex cytokine levels of aqueous humor in acute primary angle-closure patients: fellow eye comparison. BMC Ophthalmol 2016;16:6.
   PubMed Web of Science ®Google Scholar
• Kuchtey J, Kunkel J, Burgess LG, et al. Elevated transforming growth factor β1 in plasma of primary open-angle glaucoma patients. Invest Ophthalmol Vis Sci 2014;55:5291–5297.
   PubMed Web of Science ®Google Scholar
• Agarwal P, Daher AM, Agarwal R. Aqueous humor TGF-β2 levels in patients with open-angle glaucoma: A meta-analysis. Mol Vis 2015;21:612–620.
   PubMed Web of Science ®Google Scholar
• Flügel-Koch C, Ohlmann A, Fuchshofer R, et al. Thrombospondin-1 in the trabecular meshwork: localization in normal and glaucomatous eyes, and induction by TGF-beta1 and dexamethasone in vitro. Exp Eye Res 2004;79:649–663.
   PubMed Web of Science ®Google Scholar
• Kirwan RP, Wordinger RJ, Clark AF, et al. Differential global and extra-cellular matrix focused gene expression patterns between normal and glaucomatous human lamina cribrosa cells. Mol Vis 2009;15:76–88.
   PubMed Web of Science ®Google Scholar
• Schlötzer-Schrehardt U, Zenkel M, Küchle M, et al. Role of transforming growth factor-beta1 and its latent form binding protein in pseudoexfoliation syndrome. Exp Eye Res 2001;73:765–780.
   PubMed Web of Science ®Google Scholar
• Rasmussen CA, Kaufman PL. The trabecular meshwork in normal eyes and in exfoliation glaucoma. J Glaucoma 2014;23(8 Suppl 1):S15–S19.
   PubMedGoogle Scholar
• Lee KY, Rensch F, Aung T, et al. Peripapillary atrophy after acute primary angle closure. Br J Ophthalmol 2007;91:1059–1061.
   PubMed Web of Science ®Google Scholar
• Murphy-Ullrich JE, Schultz-Cherry S, Höök M. Transforming growth factor-beta complexes with thrombospondin. Mol Biol Cell 1992;3:181–188.
   PubMed Web of Science ®Google Scholar
• Crawford SE, Stellmach V, Murphy-Ullrich JE, et al. Thrombospondin-1 is a major activator of TGF-beta1 in vivo. Cell 1998;93:1159–1170.
   PubMed Web of Science ®Google Scholar
• Sweetwyne MT, Murphy-Ullrich JE. Thrombospondin1 in tissue repair and fibrosis: TGF-β-dependent and independent mechanisms. Matrix Biol 2012;31:178–186.
   PubMed Web of Science ®Google Scholar
• Penttinen RP, Kobayashi S, Bornstein P. Transforming growth factor beta increases mRNA for matrix proteins both in the presence and in the absence of changes in mRNA stability. Proc Natl Acad Sci USA 1988;85:1105–1108.
   PubMed Web of Science ®Google Scholar
• Masli S, Turpie B, Hecker KH, et al. Expression of thrombospondin in TGFbeta-treated APCs and its relevance to their immune deviation-promoting properties. J Immunol 2002;168:2264–2273.
   PubMed Web of Science ®Google Scholar
• Fuchshofer R, Yu AH, Welge-Lüssen U, et al. Bone morphogenetic protein-7 is an antagonist of transforming growth factor-beta2 in human trabecular meshwork cells. Invest Ophthalmol Vis Sci 2007;48:715–726.
   PubMed Web of Science ®Google Scholar
• Adams JC, Lawler J. The thrombospondins. Cold Spring Harb Perspect Biol 2011;3:a009712.
   PubMed Web of Science ®Google Scholar
• Masli S, Sheibani N, Cursiefen C, et al. Matricellular protein thrombospondins: influence on ocular angiogenesis, wound healing and immuneregulation. Curr Eye Res 2014;39:759–774.
   PubMed Web of Science ®Google Scholar
• Tian B, Geiger B, Epstein DL, et al. Cytoskeletal involvement in the regulation of aqueous humor outflow. Invest Ophthalmol Vis Sci 2000;41:619–623.
   PubMed Web of Science ®Google Scholar
• Ye W, Gong H, Sit A, et al. Interendothelial junctions in normal human Schlemm’s canal respond to changes in pressure. Invest Ophthalmol Vis. Sci 1997;38:2460–2468.
   PubMed Web of Science ®Google Scholar
• Nongpiur ME, Ku JY, Aung T. Angle closure glaucoma: a mechanistic review. Curr Opin Ophthalmol 2011;22:96–101.
   PubMed Web of Science ®Google Scholar
• Quigley HA, Friedman DS, Congdon NG. Possible mechanisms of primary angle-closure and malignant glaucoma. J Glaucoma 2003;12:167–180.
   PubMed Web of Science ®Google Scholar
• Quigley HA, Silver DM, Friedman DS, et al. Iris cross-sectional area decreases with pupil dilation and its dynamic behavior is a risk factor in angle closure. J Glaucoma 2009;18:173–179.
   PubMed Web of Science ®Google Scholar
• Haddadin RI, Oh DJ, Kang MH, et al. Thrombospondin-1 (TSP1)-null and TSP2-null mice exhibit lower intraocular pressures. Invest Ophthalmol Vis Sci 2012;53:6708–6717.
   PubMed Web of Science ®Google Scholar
• Wallace DM, Murphy-Ullrich JE, Downs JC, et al. The role of matricellular proteins in glaucoma. Matrix Biol 2014;37:174–182.
   PubMed Web of Science ®Google Scholar
• Tamm ER, Fuchshofer R. What increases outflow resistance in primary open-angle glaucoma? Surv Ophthalmol 2007;Suppl 2:S101–S104.
   Google Scholar
• Egan KM, Lawson JA, Fries S, et al. COX-2-derived prostacyclin confers atheroprotection on female mice. Science 2004;306:1954–1957.
   PubMed Web of Science ®Google Scholar
• Grosser T, Fries S, FitzGerald GA. Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. J Clin Invest 2006;116:4–15.
   PubMed Web of Science ®Google Scholar
• Maihöfner C, Schlötzer-Schrehardt U, Gühring H, et al. Expression of cyclooxygenase-1 and −2 in normal and glaucomatous human eyes. Invest Ophthalmol Vis Sci 2001;42:2616–2624.
   PubMed Web of Science ®Google Scholar
• Aptel F, Cucherat M, Denis P. Efficacy and tolerability of prostaglandin analogs: a meta-analysis of randomized controlled clinical trials. J Glaucoma 2008;17:667–673.
   PubMed Web of Science ®Google Scholar
• Barraza RA, McLaren JW, Poeschla EM. Prostaglandin pathway gene therapy for sustained reduction of intraocular pressure. Mol Ther 2010;18:491–501.
   PubMed Web of Science ®Google Scholar
• Kong X, Liu X, Huang X, et al. Damage to the blood-aqueous barrier in eyes with primary angle closure glaucoma. Mol Vis 2010;16:2026–2032.
   PubMed Web of Science ®Google Scholar